Funds and ETFs Almirall, S.A.

Equities

ALM

ES0157097017

Pharmaceuticals

Market Closed - BME 11:35:26 2024-04-26 am EDT 5-day change 1st Jan Change
8.57 EUR +1.24% Intraday chart for Almirall, S.A. +4.00% +1.72%

ETFs positioned on Almirall, S.A.

Name Weight AuM 1st Jan change Investor Rating
0.02% 773 M€ -.--% -
0.00% 10 M€ -3.35% -
0.00% 34 M€ +2.14% -
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
8.57 EUR
Average target price
11.21 EUR
Spread / Average Target
+30.79%
Consensus
  1. Stock Market
  2. Equities
  3. ALM Stock
  4. Funds and ETFs Almirall, S.A.